Cargando…
Rare disease patients in India are rarely involved in international orphan drug trials
We wished to determine whether rare diseases patients from India had been enrolled in international trials to develop novel orphan drugs. There are two reasons to be interested in this. (a) Different ethnic or racial groups may respond differently to a particular drug. India has huge ethnic diversit...
Autores principales: | Chakraborty, Monoswi, Choudhury, Mohua Chakraborty, Chakraborty, Indraneel, Saberwal, Gayatri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021652/ https://www.ncbi.nlm.nih.gov/pubmed/36962798 http://dx.doi.org/10.1371/journal.pgph.0000890 |
Ejemplares similares
-
Discrepancies between FDA documents and ClinicalTrials.gov for Orphan Drug-related clinical trial data
por: Choudhury, Mohua Chakraborty, et al.
Publicado: (2022) -
The role of patient organizations in the rare disease ecosystem in India: an interview based study
por: Choudhury, Mohua Chakraborty, et al.
Publicado: (2019) -
The work, goals, challenges, achievements, and recommendations of orphan medicinal product organizations in India: an interview-based study
por: Choudhury, Mohua Chakraborty, et al.
Publicado: (2019) -
Assessment of the availability of repurposed orphan drugs in India
por: Rajueni, Khujith, et al.
Publicado: (2023) -
An analysis of deficiencies in the ethics committee data of certain interventional trials registered with the Clinical Trials Registry–India
por: Chakraborty, Indraneel, et al.
Publicado: (2022)